Marc E. Lippman

2.7k total citations · 1 hit paper
16 papers, 2.2k citations indexed

About

Marc E. Lippman is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Marc E. Lippman has authored 16 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Marc E. Lippman's work include HER2/EGFR in Cancer Research (7 papers), Estrogen and related hormone effects (5 papers) and Breast Cancer Treatment Studies (3 papers). Marc E. Lippman is often cited by papers focused on HER2/EGFR in Cancer Research (7 papers), Estrogen and related hormone effects (5 papers) and Breast Cancer Treatment Studies (3 papers). Marc E. Lippman collaborates with scholars based in United States, Sweden and Italy. Marc E. Lippman's co-authors include Nancy E. Davidson, Robert B. Dickson, Robert B. Dickson, Joan Jacobson, David N. Danforth, Lori J. Pierce, Allen S. Lichter, Paul Okunieff, Seth M. Steinberg and Kenneth H. Cowan and has published in prestigious journals such as New England Journal of Medicine, Biochemistry and Journal of Cellular Physiology.

In The Last Decade

Marc E. Lippman

16 papers receiving 2.1k citations

Hit Papers

Ten-Year Results of a Comparison of Conservation with Mas... 1995 2026 2005 2015 1995 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Ten-Year Results of a Comparison of Conservation with Mastectomy in the Treatment of Stage I and II Breast Cancer
    1995 683 citations Joan Jacobson, David N. Danforth et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc E. Lippman United States 13 1.0k 854 792 474 451 16 2.2k
J R Farndon United Kingdom 17 1.5k 1.5× 610 0.7× 701 0.9× 492 1.0× 217 0.5× 39 2.3k
Hiroshi Sonoo Japan 26 1.3k 1.3× 645 0.8× 820 1.0× 476 1.0× 277 0.6× 123 2.3k
P J Carder United Kingdom 20 996 1.0× 806 0.9× 739 0.9× 756 1.6× 461 1.0× 39 2.1k
Carolyn M. Kaelin United States 19 993 1.0× 1.2k 1.4× 541 0.7× 243 0.5× 841 1.9× 26 2.4k
Sten Wingren Sweden 24 1.0k 1.0× 625 0.7× 701 0.9× 581 1.2× 443 1.0× 63 2.1k
V J Bardou France 18 1.2k 1.2× 821 1.0× 553 0.7× 548 1.2× 590 1.3× 32 2.2k
Janet S. Winston United States 24 727 0.7× 893 1.0× 570 0.7× 185 0.4× 661 1.5× 52 2.2k
M. E. Lippman United States 24 998 1.0× 599 0.7× 919 1.2× 563 1.2× 240 0.5× 57 2.1k
In Ae Park South Korea 28 1.1k 1.1× 1.1k 1.3× 609 0.8× 234 0.5× 561 1.2× 72 2.6k
Helena R. Chang United States 27 955 1.0× 1.1k 1.2× 683 0.9× 217 0.5× 498 1.1× 69 2.3k

Countries citing papers authored by Marc E. Lippman

Since Specialization
Citations

This map shows the geographic impact of Marc E. Lippman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc E. Lippman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc E. Lippman more than expected).

Fields of papers citing papers by Marc E. Lippman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc E. Lippman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc E. Lippman. The network helps show where Marc E. Lippman may publish in the future.

Co-authorship network of co-authors of Marc E. Lippman

This figure shows the co-authorship network connecting the top 25 collaborators of Marc E. Lippman. A scholar is included among the top collaborators of Marc E. Lippman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc E. Lippman. Marc E. Lippman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Tang, Careen K., et al.. (2000). Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.. PubMed. 60(11). 3081–7. 118 indexed citations
2.
Yang, Dajun, et al.. (1999). Angiopoietin-1 and Its Receptor Tie-2 Participate in the Regulation of Capillary-like Tubule Formation and Survival of Endothelial Cells. Microvascular Research. 58(3). 224–237. 152 indexed citations
3.
Eisen, Glenn M., Elizabeth A. Montgomery, Norio Azumi, et al.. (1999). Qualitative mapping of Barrett’s metaplasia: a prerequisite for intervention trials. Gastrointestinal Endoscopy. 50(6). 814–818. 26 indexed citations
4.
Tang, Careen K., et al.. (1999). Ribozyme-mediated down-regulation of ErbB-4 in estrogen receptor-positive breast cancer cells inhibits proliferation both in vitro and in vivo.. PubMed. 59(20). 5315–22. 77 indexed citations
5.
Skaar, Todd C., et al.. (1998). Two-dimensional gel electrophoresis analyses identify nucleophosmin as an estrogen regulated protein associated with acquired estrogen-independence in human breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 67(5-6). 391–402. 59 indexed citations
6.
Dickson, Robert B. & Marc E. Lippman. (1996). New approaches in the therapy of breast cancer — introduction. Breast Cancer Research and Treatment. 38(1). 1–2. 4 indexed citations
7.
Swain, Sandra M., et al.. (1995). Phase I trial of pentosan polysulfate. Investigational New Drugs. 13(1). 55–62. 12 indexed citations
8.
Jacobson, Joan, David N. Danforth, Kenneth H. Cowan, et al.. (1995). Ten-Year Results of a Comparison of Conservation with Mastectomy in the Treatment of Stage I and II Breast Cancer. New England Journal of Medicine. 332(14). 907–911. 683 indexed citations breakdown →
9.
Harris, Jay R., et al.. (1992). Breast Cancer. New England Journal of Medicine. 327(6). 390–398. 245 indexed citations
10.
Lupu, Ruth, Anton Wellstein, James P. Sheridan, et al.. (1992). Purification and characterization of a novel growth factor from human breast cancer cells. Biochemistry. 31(32). 7330–7340. 20 indexed citations
11.
Ennis, Bruce W., Marc E. Lippman, & Robert B. Dickson. (1991). The EGF Receptor System as a Target for Antitumor Therapy. Cancer Investigation. 9(5). 553–562. 121 indexed citations
12.
Valverius, Eva M., Fortunato Ciardiello, Nils‐Erik Heldin, et al.. (1990). Stromal influences on transformation of human mammary epithelial cells overexpressing c‐myc and SV40T. Journal of Cellular Physiology. 145(2). 207–216. 43 indexed citations
13.
Thompson, Erik W., Mary Beth Martin, Miguel Saceda, et al.. (1989). Regulation of Breast Cancer Cells by Hormones and Growth Factors: Effects on Proliferation and Basement Membrane Invasiveness. Hormone Research. 32(1). 242–249. 11 indexed citations
14.
Bates, Susan E., Nancy E. Davidson, Eva M. Valverius, et al.. (1988). Expression of Transforming Growth Factor α and its Messenger Ribonucleic Acid in Human Breast Cancer: Its Regulation by Estrogen and its Possible Functional Significance. Molecular Endocrinology. 2(6). 543–555. 381 indexed citations
15.
Davidson, Nancy E. & Marc E. Lippman. (1987). Stimulation of breast cancer with estrogens: How much clinical value?. European Journal of Cancer and Clinical Oncology. 23(7). 897–900. 10 indexed citations
16.
Davidson, Nancy E., Edward P. Gelmann, Marc E. Lippman, & Robert B. Dickson. (1987). Epidermal Growth Factor Receptor Gene Expression in Estrogen Receptor-Positive and Negative Human Breast Cancer Cell Lines. Molecular Endocrinology. 1(3). 216–223. 242 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J R Farndon Breakdown of academic impact, for papers by Hiroshi Sonoo Breakdown of academic impact, for papers by P J Carder Breakdown of academic impact, for papers by Carolyn M. Kaelin Breakdown of academic impact, for papers by Sten Wingren Breakdown of academic impact, for papers by V J Bardou Breakdown of academic impact, for papers by Janet S. Winston Breakdown of academic impact, for papers by M. E. Lippman Breakdown of academic impact, for papers by In Ae Park Breakdown of academic impact, for papers by Helena R. Chang
Rankless by CCL
2026